What is targeted drug therapy
Targeted drug therapy is an important breakthrough in the field of cancer treatment in recent years. It reduces damage to normal cells by accurately identifying and attacking the unique molecular targets of cancer cells. Compared with traditional chemotherapy, targeted drugs have higher selectivity and lower side effects, becoming a new hope for many cancer patients. This article will combine recent hot topics to introduce in detail the principles, applicable scenarios and latest developments of targeted drugs.
1. Working principle of targeted drugs
Targeted drugs work through the following mechanisms:
| Mechanism type | Mode of action | Representative medicine |
|---|---|---|
| signaling inhibitor | Block cancer cell growth signaling pathways | Gefitinib (lung cancer) |
| angiogenesis inhibitors | Cut off the blood supply to the tumor | Bevacizumab (colorectal cancer) |
| immune checkpoint inhibitors | Activate the immune system to attack tumors | Pembrolizumab (melanoma) |
2. Recent hot spots: Latest progress in targeted drug treatment (2023 data)
| field | Breakthrough content | Related diseases |
|---|---|---|
| KRAS target | World's first KRAS inhibitor approved | non-small cell lung cancer |
| bispecific antibodies | Targets CD3 and BCMA simultaneously | multiple myeloma |
| ADC drugs | New antibody conjugate drugs launched | breast cancer |
3. Comparison of the advantages and disadvantages of targeted drug therapy
| Advantages | limitations |
|---|---|
| Precisely target cancer cells | Requires matching of specific genetic mutations |
| Side effects are relatively minor | possible drug resistance |
| Some patients have significant results | Treatment costs are higher |
4. Applicable groups and testing requirements
Genetic testing is required before targeted therapy. The following are common testing items:
| Test items | Applicable cancer types | Detection rate |
|---|---|---|
| EGFR mutation | non-small cell lung cancer | About 50% of Asian people |
| HER2 amplification | breast cancer | 20-30% of patients |
| BRCA mutations | ovarian cancer | About 15% of patients |
5. Five issues that patients are most concerned about
1.Treatment cost:Some targeted drugs have been included in medical insurance, and annual treatment costs range from tens to hundreds of thousands.
2.Medication cycle:Usually continued until disease progression or intolerable toxicity occurs
3.Side Effect Management:Common skin rashes, diarrhea, etc. require the guidance of a professional doctor.
4.Resistance response:New target drugs can be found through secondary genetic testing
5.Combination treatment:More and more studies support the combination of targeted drugs and immunotherapy
6. Future development trends
According to recent disclosures at international academic conferences, the research and development of targeted drugs presents three major directions:
1. New technological breakthroughs targeting "undruggable" targets
2. Artificial intelligence-assisted drug design accelerates development process
3. Optimize individualized treatment plans to improve response rate
Targeted therapy is rewriting the landscape of cancer treatment, and with the development of precision medicine, more patients will benefit from it in the future. Patients should choose the most suitable treatment plan based on their own conditions under the guidance of a professional doctor.
check the details
check the details
en
